Questcor reports positive clinical trial results of Acthar in nephrotic syndrome patients

US-based biopharmaceutical firm Questcor Pharmaceuticals has reported results from an investigator-initiated clinical trial evaluating the dosing and effectiveness of HP Acthar Gel (repository corticotropin) in 20 patients with nephrotic syndrome due…
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news